Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HZG9
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005509 | calcium ion binding | 5 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.659 |
CLV_PCSK_PC1ET2_1 | 12 | 14 | PF00082 | 0.659 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.742 |
CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.422 |
DEG_APCC_DBOX_1 | 79 | 87 | PF00400 | 0.429 |
DOC_CDC14_PxL_1 | 195 | 203 | PF14671 | 0.488 |
DOC_CYCLIN_yCln2_LP_2 | 197 | 200 | PF00134 | 0.503 |
DOC_CYCLIN_yCln2_LP_2 | 85 | 91 | PF00134 | 0.488 |
DOC_PP1_RVXF_1 | 59 | 66 | PF00149 | 0.488 |
DOC_PP2B_LxvP_1 | 197 | 200 | PF13499 | 0.503 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.549 |
DOC_USP7_MATH_1 | 210 | 214 | PF00917 | 0.421 |
DOC_USP7_MATH_1 | 220 | 224 | PF00917 | 0.207 |
DOC_USP7_MATH_2 | 88 | 94 | PF00917 | 0.526 |
LIG_14-3-3_CanoR_1 | 61 | 66 | PF00244 | 0.573 |
LIG_BIR_III_2 | 193 | 197 | PF00653 | 0.469 |
LIG_deltaCOP1_diTrp_1 | 175 | 180 | PF00928 | 0.379 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.522 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.466 |
LIG_FHA_1 | 25 | 31 | PF00498 | 0.628 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.428 |
LIG_FHA_2 | 18 | 24 | PF00498 | 0.656 |
LIG_LIR_Gen_1 | 175 | 184 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 50 | 58 | PF02991 | 0.511 |
LIG_LIR_Gen_1 | 98 | 109 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 137 | 143 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 193 | 198 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 77 | 82 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 98 | 104 | PF02991 | 0.432 |
LIG_LYPXL_S_1 | 156 | 160 | PF13949 | 0.424 |
LIG_LYPXL_yS_3 | 157 | 160 | PF13949 | 0.432 |
LIG_MYND_1 | 196 | 200 | PF01753 | 0.496 |
LIG_PCNA_yPIPBox_3 | 127 | 140 | PF02747 | 0.487 |
LIG_PDZ_Class_1 | 226 | 231 | PF00595 | 0.528 |
LIG_SH2_CRK | 170 | 174 | PF00017 | 0.433 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.484 |
LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.572 |
LIG_SH2_STAP1 | 52 | 56 | PF00017 | 0.358 |
LIG_SH2_STAP1 | 96 | 100 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.437 |
LIG_SH3_3 | 193 | 199 | PF00018 | 0.582 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.538 |
LIG_SUMO_SIM_anti_2 | 81 | 87 | PF11976 | 0.464 |
LIG_SUMO_SIM_par_1 | 120 | 125 | PF11976 | 0.533 |
LIG_TRAF2_1 | 68 | 71 | PF00917 | 0.655 |
LIG_TRFH_1 | 195 | 199 | PF08558 | 0.391 |
LIG_WRC_WIRS_1 | 62 | 67 | PF05994 | 0.496 |
MOD_CK1_1 | 103 | 109 | PF00069 | 0.583 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.511 |
MOD_CK1_1 | 185 | 191 | PF00069 | 0.458 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.566 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.510 |
MOD_GlcNHglycan | 189 | 193 | PF01048 | 0.505 |
MOD_GlcNHglycan | 212 | 215 | PF01048 | 0.385 |
MOD_GlcNHglycan | 31 | 35 | PF01048 | 0.634 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.531 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.497 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.470 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.669 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.476 |
MOD_LATS_1 | 129 | 135 | PF00433 | 0.543 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.503 |
MOD_NEK2_1 | 226 | 231 | PF00069 | 0.490 |
MOD_NEK2_2 | 96 | 101 | PF00069 | 0.417 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.474 |
MOD_Plk_1 | 22 | 28 | PF00069 | 0.768 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.450 |
MOD_Plk_4 | 96 | 102 | PF00069 | 0.448 |
MOD_SUMO_rev_2 | 144 | 150 | PF00179 | 0.563 |
TRG_DiLeu_BaEn_1 | 81 | 86 | PF01217 | 0.464 |
TRG_DiLeu_BaLyEn_6 | 193 | 198 | PF01217 | 0.453 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.521 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.358 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.481 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NI68 | Trypanosomatidae | 31% | 73% |
A0A3S5H7A2 | Leishmania donovani | 99% | 100% |
A0A422N8A3 | Trypanosoma rangeli | 32% | 78% |
A4HC26 | Leishmania braziliensis | 70% | 100% |
D0A106 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 76% |
E9AVF9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QC20 | Leishmania major | 90% | 100% |
V5B1W6 | Trypanosoma cruzi | 33% | 77% |